Remimazolam Tosylate

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Anesthesia

Conditions

Anesthesia

Trial Timeline

Jul 23, 2014 → Aug 16, 2014

About Remimazolam Tosylate

Remimazolam Tosylate is a phase 1 stage product being developed by Jiangsu Hengrui Medicine for Anesthesia. The current trial status is completed. This product is registered under clinical trial identifier NCT03444480. Target conditions include Anesthesia.

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT03444480Phase 1Completed

Competing Products

20 competing products in Anesthesia

See all competitors